Penbrook Management LLC Novo Nordisk A S Transaction History

Penbrook Management LLC

$125 Million
Q2 2025

A detailed history of Penbrook Management LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Penbrook Management LLC holds 311,400 shares of NVO stock, worth $17.5 Million. This represents 17.15% of its overall portfolio holdings.

Number of Shares

311,400

Previous 311,400 -0.0%

Holding current value

$17.5 Million

Previous $21.5 Million -0.0%

% of portfolio

17.15%

Previous 16.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 01, 2025	SELL	$69.3 - $90.95 $69,300 - $90,950	-1,000 Reduced 0.32%	311,400 $21.6 Million
Q4 2024 Jan 23, 2025	SELL	$85.0 - $120.04 $8,500 - $12,004	-100 Reduced 0.03%	312,400 $26.9 Million
Q3 2024 Oct 15, 2024	SELL	$119.07 - $145.42 $11,907 - $14,541	-100 Reduced 0.03%	312,500 $37.2 Million
Q1 2024 Apr 18, 2024	SELL	$102.11 - $135.92 $61,266 - $81,551	-600 Reduced 0.19%	312,600 $40.1 Million
Q4 2023 Jan 16, 2024	SELL	$87.78 - $105.45 $351,120 - $421,800	-4,000 Reduced 1.26%	313,200 $32.4 Million
Q3 2023 Oct 10, 2023	BUY	$90.94 - $199.54 $14.4 Million - $31.6 Million	158,600 Added 100.0%	317,200 $28.8 Million
Q2 2023 Jul 17, 2023	SELL	$155.98 - $172.65 $93,588 - $103,590	-600 Reduced 0.38%	158,600 $25.7 Million
Q1 2023 Apr 20, 2023	SELL	$132.34 - $159.14 $119,106 - $143,226	-900 Reduced 0.56%	159,200 $25.3 Million
Q4 2022 Jan 24, 2023	SELL	$102.55 - $135.33 $1.13 Million - $1.5 Million	-11,050 Reduced 6.46%	160,100 $0
Q3 2022 Oct 31, 2022	SELL	$95.28 - $116.93 $47,640 - $58,465	-500 Reduced 0.29%	171,150 $17.1 Million
Q3 2021 Oct 26, 2021	SELL	$84.42 - $106.62 $25,326 - $31,986	-300 Reduced 0.17%	171,650 $16.5 Million
Q1 2021 May 05, 2021	SELL	$67.06 - $75.82 $1.33 Million - $1.51 Million	-19,900 Reduced 10.37%	171,950 $11.6 Million
Q1 2021 Apr 16, 2021	BUY	$67.06 - $75.82 $1.34 Million - $1.52 Million	20,000 Added 11.64%	191,850 $11.5 Million
Q4 2020 Apr 25, 2022	SELL	$63.89 - $73.8 $1.28 Million - $1.48 Million	-20,000 Reduced 10.42%	171,850 $12 Million
Q4 2020 Jan 27, 2021	BUY	$63.89 - $73.8 $4.15 Million - $4.8 Million	65,000 Added 51.24%	191,850 $13.4 Million
Q3 2020 Oct 23, 2020	BUY	$63.69 - $70.22 $31,845 - $35,110	500 Added 0.4%	126,850 $8.81 Million
Q1 2020 Apr 14, 2020	SELL	$49.46 - $64.78 $24,730 - $32,390	-500 Reduced 0.39%	126,350 $7.61 Million
Q3 2019 Oct 11, 2019	SELL	$47.54 - $53.43 $9,508 - $10,686	-200 Reduced 0.16%	126,850 $6.56 Million
Q2 2019 Jul 15, 2019	SELL	$46.79 - $52.47 $46,790 - $52,470	-1,000 Reduced 0.78%	127,050 $6.49 Million
Q4 2018 Feb 01, 2019	SELL	$41.54 - $47.25 $22,847 - $25,987	-550 Reduced 0.43%	128,050 $5.9 Million
Q1 2018 Apr 27, 2018	SELL	$48.49 - $58.14 $24,245 - $29,070	-500 Reduced 0.39%	128,600 $6.33 Million
Q4 2017 Feb 21, 2018	BUY	$47.53 - $53.73 $6.14 Million - $6.94 Million	129,100	129,100 $6.93 Million

Others Institutions Holding NVO

# of Institutions

1,729

Shares Held

313M

Call Options Held

13.7M

Put Options Held

19.7M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $127B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Penbrook Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penbrook Management LLC with notifications on news.

Account

Penbrook Management LLC Novo Nordisk A S Transaction History